Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-23 Sale | 2024-10-25 4:25 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 4,361 | $29.53 | $128,780 | 322,878 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:23 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,189 | $29.53 | $94,171 | 134,971 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 4:21 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,740 | $29.53 | $80,912 | 142,186 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:31 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 9,095 | $28.79 | $261,845 | 994,789 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:30 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,188 | $28.79 | $91,783 | 365,144 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:28 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,860 | $28.79 | $82,339 | 327,239 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:27 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,271 | $28.79 | $94,172 | 335,343 (Direct) | View |
| 2024-10-09 Sale | 2024-10-11 4:04 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 5,162 | $29.56 | $152,589 | 338,614 (Direct) | View |
| 2024-10-09 Sale | 2024-10-11 4:02 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,460 | $29.56 | $131,838 | 1,003,884 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:15 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,295 | $31.86 | $104,976 | 330,099 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:14 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,027 | $31.86 | $96,437 | 368,332 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:11 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,768 | $31.86 | $120,045 | 343,776 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:10 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 3,027 | $31.86 | $96,437 | 440,959 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 4:07 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 15,068 | $31.86 | $480,052 | 1,008,344 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:20 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,813 | $27.76 | $78,089 | 144,926 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:19 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,456 | $27.76 | $95,939 | 138,160 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:17 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 4,015 | $27.76 | $111,456 | 333,394 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:42 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,505 | $29.69 | $74,382 | 337,409 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:41 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,044 | $29.69 | $90,386 | 371,359 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:39 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,123 | $29.69 | $92,733 | 347,544 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:38 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 2,867 | $29.69 | $85,132 | 443,986 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:36 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 8,685 | $29.69 | $257,888 | 1,023,412 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:07 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,747 | $28.06 | $133,201 | 350,667 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:06 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,527 | $28.06 | $42,848 | 446,853 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:04 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,619 | $28.06 | $129,609 | 1,032,097 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:18 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,042 | $29.65 | $119,845 | 355,414 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:15 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 16,163 | $29.65 | $479,233 | 1,036,716 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:14 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 3,247 | $29.65 | $96,274 | 448,380 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:13 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,247 | $29.65 | $96,274 | 374,403 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:10 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,242 | $29.65 | $96,125 | 339,914 (Direct) | View |
| 2024-04-24 Sale | 2024-04-26 5:22 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,261 | $28.9 | $94,243 | 141,616 (Direct) | View |
| 2024-04-24 Sale | 2024-04-26 5:20 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 7,239 | $28.9 | $209,207 | 147,739 (Direct) | View |
| 2024-04-24 Sale | 2024-04-26 5:18 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,963 | $28.9 | $114,531 | 343,156 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:06 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 9,827 | $29.06 | $285,554 | 347,119 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:05 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 8,280 | $29.06 | $240,602 | 377,650 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:01 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 12,253 | $29.06 | $356,049 | 359,456 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 5:59 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 10,115 | $29.06 | $293,923 | 451,627 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 5:57 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 34,079 | $29.06 | $990,269 | 1,052,879 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-18 Option Award | 2024-11-20 5:15 pm | N/A 2034-11-18 | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 247,402 | $0 | 247,402 (Direct) | View |